Biovision Technologies, Inc.

Biovision Technologies, Inc., a small business subchapter S corporation headquartered in Downingtown, Pennsylvania, manufactures and supplies precision scientific imaging equipment, specialized optical instruments, and microscopy systems to federal research agencies as a prime contractor under small business set-asides and full-and-open procurements. The vendor operates exclusively as a prime (100% of awards), with no subcontract footprint, and competes across mixed set-aside posture — about half of recent awards carry total small business designations, the remainder full-and-open.

Biovision's capability portfolio centers on metrology-grade digital cameras, fluorescence and confocal microscope systems, illumination and imaging software, and precision optical measurement equipment. Representative work includes a $84,445 total small business purchase order from Warner Robins Air Logistics Complex in July 2025 for a Hamamatsu Orca Quest qCMOS metrology-grade digital camera with single-photon measurement capability, originally sourced through a NIST sources-sought notice; a $43,800 total small business award from the Department of Veterans Affairs in December 2024 for a Hamamatsu Orca Quest qCMOS Digital Camera Kit; and a $30,500 total small business purchase order from the National Heart, Lung and Blood Institute in August 2023 for a Teledyne Photometrics Prime 95B research camera. Biovision has also delivered microscope imaging workstations, stage incubators for live-cell imaging, linear encoder measurement components, and acquisition software to NIH institutes.

Customer concentration is tightly clustered within HHS research agencies. The top five customer organizations account for 37% of all awards by count, dominated by National Institutes of Health institutes — the National Cancer Institute leads with 28 awards ($989 thousand combined potential value), followed by the National Heart, Lung and Blood Institute (20 awards, $539 thousand) and the National Institute on Drug Abuse (14 awards, $591 thousand). By potential-value ranking, the same three institutes occupy the top tier, accounting for 48% of combined potential value across all awards. The National Institute of Neurological Disorders and Stroke, the National Institute of Environmental Health Sciences, and the Department of Veterans Affairs round out the active customer set.

The vendor's award volume has declined in recent years — four awards in 2022 declining to one annual award each in 2024, 2025, and 2026 (most recent, June 22, 2026, a $19,596 PE-4000 illumination system to NINDS). Across a 228-award lifetime footprint spanning 1999 to present, Biovision has accumulated $5.5 million in combined potential value, with $6.2 million in obligated dollars. One award ($20 thousand) faces ultimate completion within the next twenty-four months. The vendor's primary NAICS concentration is Analytical Laboratory Instrument Manufacturing (123 awards), with secondary exposure in Optical Instrument and Lens Manufacturing and Professional, Scientific, and Technical Services. Purchase orders dominate the transaction model; task orders appear on five NIH Blanket Purchase Agreements, each carrying nominal single task-order volume. Work is performed at Biovision facilities in Downingtown and Exton, Pennsylvania, with some specialized camera manufacturing subcontracted to Japan-based suppliers.